-
Rewind to 1997: President Clinton announces a 10-year goal for the development of an HIV/ AIDS vaccine. Fast forward to 2007. Are you able to provide such a vaccine to your patients?
-
Results from a recently published study suggest that combination oral contraceptives (OCs) and oral medroxyprogesterone acetate (MPA) may be effective treatment options for acute uterine bleeding.
-
Nurse practitioners, physician assistants, and certified nurse-midwives provide many health services in family planning, yet many of their training programs do not provide didactic or clinical education about abortion services, results from a recently published survey show.
-
Choosing depot medroxyprogesterone acetate (DMPA, Depo Provera, Pfizer, New York City) may free women from taking a daily pill, but they must return to providers' offices for quarterly injections. What if pharmacists could administer repeat injections?
-
Non-healing wounds represent a significant cause of morbidity and mortality for a large portion of the adult population. Wounds that fail to heal are entrapped in a self-sustaining cycle of inflammation. Treatments are aimed at the underlying cause of the wounds.
-
-
Because of adverse effects, special care should be used when prescribing the atypical antipsychotic drugs for patients with dementia.
-
This study addresses the role of nutritional status in the disablement process. Low serum concentrations of vitamins B6, B12 and selenium seem to predict subsequent disability in activities of daily living (ADLs) in older women living in the community.
-
Evaluation of a large United Kingdom (UK) database supports a dose-related association with hip fracture. There appears to be a correlation between PPI use, including dosage and chronicity, and occurrence of hip fractures in patients over age 50.
-
The FDA has approved a new atypical antipsychotic agent. Paliperidone is the active metabolite of risperidone. The drug is formulated in an osmotic drug delivery system (OROS) developed by ALZA.
